<DOC>
	<DOCNO>NCT02256319</DOCNO>
	<brief_summary>This clinical trial design study compare change deep brain activity ( field potential ) Parkinson 's disease ( PD ) patient awake , sedation dexmedetomidine propofol . The recording make deep brain stimulation ( DBS ) electrode implant PD management . The investigator hypothesize dexmedetomidine produce few change compare propofol , change consistent recognizable compare activity patient expose sedation . Typification change would future allow patient undergo surgery comfortably compromise quality record final clinical outcome . The principal variable analyze signal 's power frequency band , absolute relative . The analysis include usual clinical method rapid Fourier transform ( FFT ) window fast Fourier transform ( WFFT ) , wavelet analysis , Gabor , coherence .</brief_summary>
	<brief_title>Dexmedetomidine v Propofol Recordings Deep Brain Activity Measured Through Implanted Stimulators</brief_title>
	<detailed_description>Comparative clinical trial , non blind , control sequential , evaluate effect propofol dexmedetomidine basal ganglia PD patient DBS electrode . It phase IV clinical trial evaluate effect drug outside approve . The study take part three phase : 1 . DBS placement sedation dexmedetomidine 0.2 μg/kg/h . This call `` dexmedetomidine record '' . 2 . Four day later sedation , record register one specialize electrically isolated room Neurophysiology Department . This dubbed `` basal record '' . The equipment use also standard one use routine postoperative recording . 3 . 5 day initial surgery , follow protocol place procedure , tunnelization battery placement take place . This do general anaesthesia . During anaesthetic induction , patient expose incremental dos propofol . Different plasmatic concentration target use mathematical model target control infusion ( TCI ) pump . These recording call `` propofol 0.5 , 1 , 1.5 , 2 , 2.5 μg/mL '' .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Capacity understand , consent commit three phase study . Older 18 year old . The patient schedule DBS electrode placement PD treatment neurologist . Allergy hypersensibility dexmedetomidine propofol Cardiac blockade ( type 2 3 ) without implant pacemaker Low blood pressure ( mean &lt; 60 mmHg ) symptom low cardiac output . Severe cerebrovascular disease . Pregnancy nurse mother .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Deep brain stimulation</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Propofol</keyword>
</DOC>